A single-parasite transcriptional atlas of Toxoplasma gondii reveals novel control of antigen expression
Abstract
Toxoplasma gondii, a protozoan parasite, undergoes a complex and poorly understood developmental process that is critical for establishing a chronic infection in its intermediate hosts. Here, we applied single-cell RNA-sequencing (scRNA-seq) on >5,400 Toxoplasma in both tachyzoite and bradyzoite stages using three widely studied strains to construct a comprehensive atlas of cell-cycle and asexual development, revealing hidden states and transcriptional factors associated with each developmental stage. Analysis of SAG1-related sequence (SRS) antigenic repertoire reveals a highly heterogeneous, sporadic expression pattern unexplained by measurement noise, cell cycle, or asexual development. Furthermore, we identified AP2IX-1 as a transcription factor that controls the switching from the ubiquitous SAG1 to rare surface antigens not previously observed in tachyzoites. In addition, comparative analysis between Toxoplasma and Plasmodium scRNA-seq results reveals concerted expression of gene sets, despite fundamental differences in cell division. Lastly, we built an interactive data-browser for visualization of our atlas resource.
Data availability
Instructions to obtain processed data, preprocessing scripts, and analysis scripts are available on https://github.com/xuesoso/singleToxoplasmaSeq.Raw fastq files and processed data are deposited on SRA and GEO repository (GEO number: GSE145080)
-
Data from: A single-parasite transcriptional landscape of Toxoplasma gondii reveals novel control of antigen expressionDryad Digital Repository, 10.5061/dryad.kprr4xh17.
-
Coordinated progression through two subtranscriptomes underlies the tachyzoite cycle of toxoplasma gondiiNCBI Gene Expression Omnibus, GSE19092.
-
Transcriptomics of Toxoplasma gondii enteroepithelial stagesNCBI Gene Expression Omnibus, GSE108740.
Article and author information
Author details
Funding
Stanford University (Stanford Interdisciplinary Graduate Bio-X Fellowships)
- Yuan Xue
- Terence C Theisen
National Institutes of Health (F30 AI124589-03)
- Suchita Rastogi
National Institutes of Health (5T32AI007328-30)
- Abel Ferrel
Howard Hughes Medical Institute (Gilliams Fellowship for Advanced Study)
- Abel Ferrel
National Institutes of Health (RO1 AI21423)
- John C Boothroyd
National Institutes of Health (RO1 AI29529)
- John C Boothroyd
Chan Zuckerberg Biohub
- Stephen R Quake
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2020, Xue et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 5,276
- views
-
- 679
- downloads
-
- 51
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Cancer Biology
- Cell Biology
Cell crowding causes high-grade breast cancer cells to become more invasive by activating a molecular switch that causes the cells to shrink and spread.
-
- Cell Biology
Overnutrition engenders the expansion of adipose tissue and the accumulation of immune cells, in particular, macrophages, in the adipose tissue, leading to chronic low-grade inflammation and insulin resistance. In obesity, several proinflammatory subpopulations of adipose tissue macrophages (ATMs) identified hitherto include the conventional ‘M1-like’ CD11C-expressing ATM and the newly discovered metabolically activated CD9-expressing ATM; however, the relationship among ATM subpopulations is unclear. The ER stress sensor inositol-requiring enzyme 1α (IRE1α) is activated in the adipocytes and immune cells under obesity. It is unknown whether targeting IRE1α is capable of reversing insulin resistance and obesity and modulating the metabolically activated ATMs. We report that pharmacological inhibition of IRE1α RNase significantly ameliorates insulin resistance and glucose intolerance in male mice with diet-induced obesity. IRE1α inhibition also increases thermogenesis and energy expenditure, and hence protects against high fat diet-induced obesity. Our study shows that the ‘M1-like’ CD11c+ ATMs are largely overlapping with but yet non-identical to CD9+ ATMs in obese white adipose tissue. Notably, IRE1α inhibition diminishes the accumulation of obesity-induced metabolically activated ATMs and ‘M1-like’ ATMs, resulting in the curtailment of adipose inflammation and ensuing reactivation of thermogenesis, without augmentation of the alternatively activated M2 macrophage population. Our findings suggest the potential of targeting IRE1α for the therapeutic treatment of insulin resistance and obesity.